Dr. Claus Roehrborn is a world-renowned urologist and expert in prostate diseases with over three decades of distinguished service at UT Southwestern Medical Center. He currently serves as Professor and Chair of the Department of Urology, holding the prestigious E. E. Fogelson and Greer Garson Fogelson Distinguished Chair in Urology and the S.T. Harris Family Chair in Medical Science. Originally from Germany, Dr. Roehrborn earned his medical degree from Justus Liebig University in Giessen before completing his surgical residency at the German Army Hospital. He relocated to Dallas in 1984 to pursue advanced training in urologic endocrinology at UT Southwestern, where he joined the faculty in 1992 and assumed leadership of the Department of Urology in 2002.
Dr. Roehrborn has pioneered innovative approaches to treating both cancerous and benign prostate conditions, performing over 3 000 DaVinci robotic prostatectomies for prostate cancer and nearly 1 000 robotic prostatectomies for benign prostatic hyperplasia. His research has significantly advanced the field through the development and refinement of minimally invasive procedures including Urolift, REZUM, and Aquablation, which have transformed patient care standards for prostate conditions. With a Google Scholar citation count exceeding 66 000, his work has established him as a leading authority whose clinical innovations have directly improved outcomes for thousands of patients worldwide. His commitment to advancing medical therapy for prostate diseases has made him instrumental in shaping modern urological practice and establishing UT Southwestern's Department of Urology as a nationally ranked leader in the specialty.
Under Dr. Roehrborn's leadership, UT Southwestern's Department of Urology has expanded to encompass 35 MD providers, 15 midlevel providers, and serves over 75 000 outpatient clinic visits annually. His personal clinical approach emphasizes direct patient care, as he maintains hands-on involvement in diagnostic evaluations, prostate biopsies, and surgical procedures to ensure personalized treatment for each patient. Recognized with the prestigious Patricia and William L. Watson Jr. M.D. Award for Excellence in Clinical Medicine in 2010, Dr. Roehrborn continues to be honored annually as a Best Doctor by D Magazine and a Super Doctor by Texas Monthly. His ongoing research focuses on further refining minimally invasive therapies for prostate conditions while maintaining his leadership role in advancing the field of urology through mentorship, clinical excellence, and continued innovation.
